SFG
NUVB icon

SageGuard Financial Group’s Nuvation Bio NUVB Stock Holding History

SageGuard Financial Group’s Portfolio NUVB Stock Details NUVB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$83.4K Sell
14,683
-5,181
-26% -$25.3K 0.01% 211
2026
Q1 		$85.2K Sell
19,864
-430
-2% -$2.4K 0.01% 196
2025
Q4 		$182K Buy
+20,294
New +$126K 0.03% 174

Other funds holding NUVB

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
ACM
ACT Capital Management Wayne, Pennsylvania $153M AUM
Russell Investments Group
Russell Investments Group London, United Kingdom $114B AUM 41.71% 1-Year Est. Return
HWAM
Hennion & Walsh Asset Management Parsippany, New Jersey $3.5B AUM 41.95% 1-Year Est. Return
TE
Tema ETFs New York $3.09B AUM 72.72% 1-Year Est. Return
AA
ALPS Advisors Denver, Colorado $21.3B AUM 23.41% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
LCM
Legato Capital Management San Francisco, California $1.21B AUM 82.36% 1-Year Est. Return

SageGuard Financial Group's NUVB Position: Q2 2026 in Review

SageGuard Financial Group reduced its Nuvation Bio (NUVB) stake by 26% in Q2 2026, selling an estimated $25.3K and leaving 14,683 shares worth $83.4K. The position accounts for 0.01% of the portfolio, ranked #211.

SageGuard Financial Group first reported a position in NUVB in Q4 2025 and has held it in 3 quarters since. The position peaked at $182K in Q4 2025. 84 funds tracked by Wall St. Rank hold NUVB as of Q2 2026.

  • SageGuard Financial Group held 14,683 shares of Nuvation Bio worth $83.4K as of Q2 2026.
  • SageGuard Financial Group sold 5,181 Nuvation Bio shares in Q2 2026, an estimated $25.3K.
  • Nuvation Bio made up 0.01% of SageGuard Financial Group's portfolio in Q2 2026, its #211 holding.
  • SageGuard Financial Group first reported a position in Nuvation Bio in Q4 2025 and has held it in 3 quarters since.
  • SageGuard Financial Group's Nuvation Bio position peaked at $182K in Q4 2025.
  • 84 funds tracked by Wall St. Rank held Nuvation Bio as of Q2 2026.

Based on SageGuard Financial Group's 13F filing for Q2 2026, filed 27 Jul 2026.